Open AccessComparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe
Author(s) -
Kate Soldan,
Joakim Dillner
Publication year - 2006
Language(s) - English
Resource type - Journals
ISSN - 9999-1233
DOI - 10.2807/esw.11.47.03085-en
Subject(s) - human papillomavirus vaccine , human papillomavirus , virology , medicine , gardasil , cervical cancer , cancer
A quadrivalent vaccine against human papillomavirus types 16, 18, 6 and 11, known as Gardasil was granted a marketing license by the European Commission in September 2006